Asparaginase Encapsulated in Erythrocytes for Patients With ALL and Hypersensitivity to PEG-asparaginase
Clinical trial NCT03267030 · COMPLETED
Trial details
- NCT number
- NCT03267030
- Sponsor
- Birgitte Klug Albertsen
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-23
- Primary completion
- 2020-08-01
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.